isoxazoles has been researched along with Abnormalities, Drug-Induced in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (23.53) | 18.2507 |
| 2000's | 8 (47.06) | 29.6817 |
| 2010's | 5 (29.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beck, E; Schaefer, C; Tissen-Diabaté, T; Weber-Schoendorfer, C | 1 |
| Cagnoli, GA; Cassina, M; Clementi, M; Di Gianantonio, E; Zuccarello, D | 1 |
| Fukushima, R; Hirashiba, M; Hishikawa, A; Kanamori, S; Kaneto, M; Kitagawa, H; Muranaka, R | 2 |
| Chambers, CD | 1 |
| Braddock, SR; Cassina, M; Chambers, CD; Jimenez, JL; Johnson, DL; Jones, KL; Luo, YJ; Mirrasoul, N; Robinson, LK; Salas, E; Xu, R | 1 |
| Engeland, A; Furu, K; Viktil, KK | 1 |
| Ohtahara, S; Yamatogi, Y | 2 |
| Badgwell, C; Rosen, T | 1 |
| Chambers, C; Johnson, D; Jones, KL; Koren, G; Tutuncu, ZN | 1 |
| Amano, Y; Egawa, I; Kaneko, S; Kondo, T | 1 |
| Koren, G; Kozer, E; Moretti, ME | 1 |
| Chambers, CD; Johnson, DL; Lyons Jones, K | 1 |
| Martson', LV; Nedopitnskaia, NN; Shepel'skaia, NR | 1 |
| Fujii, S; Furukawa, S; Haguro, S; Morinaga, T; Morino, K; Toteno, I; Yamakita, O | 1 |
| Fuchigami, K; Kodama, R; Matsunaga, K; Otsuka, T; Sameshima, K; Yamakita, O | 1 |
2 review(s) available for isoxazoles and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
Cutaneous sarcoidosis therapy updated.
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Allopurinol; Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antigen Presentation; Antimalarials; Chlorambucil; Contraindications; Cyclosporine; Cytokines; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Isoxazoles; Laser Therapy; Leflunomide; Male; Melatonin; Methotrexate; Models, Immunological; Pentoxifylline; Pregnancy; Pregnancy Complications; Sarcoidosis; Skin Diseases; Tetracyclines; Th1 Cells; Thalidomide | 2007 |
Are new agents used to treat rheumatoid arthritis safe to take during pregnancy? Organization of Teratology Information Specialists (OTIS) study.
Topics: Abnormalities, Drug-Induced; Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Female; Humans; Incidence; Information Services; Isoxazoles; Leflunomide; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimester, First; Risk Assessment; Sulfasalazine; Teratogens | 2007 |
15 other study(ies) available for isoxazoles and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
Leflunomide - A human teratogen? A still not answered question. An evaluation of the German Embryotox pharmacovigilance database.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Antirheumatic Agents; Arthritis, Rheumatoid; Esophageal Atresia; Female; Germany; Humans; Infant, Newborn; Isoxazoles; Leflunomide; Male; Maternal-Fetal Exchange; Pharmacovigilance; Pregnancy; Pregnancy Trimester, First; Teratogens; Tracheoesophageal Fistula; Young Adult | 2017 |
Human teratogens and genetic phenocopies. Understanding pathogenesis through human genes mutation.
Topics: Abnormalities, Drug-Induced; Angiotensin-Converting Enzyme Inhibitors; Animals; Female; Fetal Diseases; Fetus; Fluconazole; Humans; Isoxazoles; Leflunomide; Mutation; Mycophenolic Acid; Phenotype; Pregnancy; Teratogenesis; Teratogens; Thalidomide; Warfarin | 2017 |
Inhibiting the teratogenicity of the immunosuppressant leflunomide in mice by supplementation of exogenous uridine.
Topics: Abnormalities, Drug-Induced; Animals; Dihydroorotate Dehydrogenase; Embryonic Development; Female; Fetal Viability; Fetus; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mice; Mice, Inbred ICR; Oxidoreductases Acting on CH-CH Group Donors; Pregnancy; Pyrimidine Nucleotides; Teratogens; Uridine | 2009 |
Critical periods for the teratogenicity of immune-suppressant Leflunomide in mice.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Adjuvants, Immunologic; Animals; Critical Period, Psychological; Embryo Loss; Embryo, Mammalian; Female; Fetal Viability; Gestational Age; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Mice; Mice, Inbred ICR; Pregnancy | 2009 |
Value of the small cohort study including a physical examination for minor structural defects in identifying new human teratogens.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Antidepressive Agents; Arthritis, Rheumatoid; Carbamazepine; Case-Control Studies; Cohort Studies; Female; Fever; Fluoxetine; Humans; Isoxazoles; Leflunomide; Maternal Exposure; Neural Tube Defects; Physical Examination; Pregnancy; Prospective Studies; Research Design; Teratogens; Tretinoin | 2011 |
Pregnancy outcome in women exposed to leflunomide before or during pregnancy.
Topics: Abnormalities, Drug-Induced; Antirheumatic Agents; Chondrodysplasia Punctata; Ductus Arteriosus, Patent; Ectodermal Dysplasia; Female; Heart Block; Humans; Isoxazoles; Leflunomide; Pierre Robin Syndrome; Pregnancy; Pregnancy Outcome; Prospective Studies; Rheumatic Diseases; Spina Bifida Occulta | 2012 |
Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers.
Topics: Abnormalities, Drug-Induced; Adalimumab; Adolescent; Adult; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Cohort Studies; Databases, Factual; Drug Utilization Review; Etanercept; Fathers; Female; Humans; Immunoglobulin G; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Mothers; Norway; Pregnancy; Pregnancy Outcome; Receptors, Tumor Necrosis Factor; Registries; Risk Factors; Young Adult | 2012 |
Safety of zonisamide therapy: prospective follow-up survey.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Age Factors; Aged; Anticonvulsants; Child; Child, Preschool; Drug Therapy, Combination; Epilepsy; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Incidence; Infant; Isoxazoles; Male; Mental Disorders; Middle Aged; Product Surveillance, Postmarketing; Zonisamide | 2004 |
Erratum to "Safety of zonisamide therapy: prospective follow-up survey.".
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Age Factors; Aged; Anticonvulsants; Child; Child, Preschool; Drug Therapy, Combination; Epilepsy; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Incidence; Infant; Isoxazoles; Male; Mental Disorders; Middle Aged; Product Surveillance, Postmarketing; Zonisamide | 2007 |
Preliminary report on teratogenic effects of zonisamide in the offspring of treated women with epilepsy.
Topics: Abnormalities, Drug-Induced; Adult; Anencephaly; Anticonvulsants; Epilepsy; Female; Humans; Infant, Newborn; Isoxazoles; Polypharmacy; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prospective Studies; Risk Factors; Zonisamide | 1996 |
Leflunomide: new antirheumatic drug. Effect on pregnancy outcomes.
Topics: Abnormalities, Drug-Induced; Adult; Arthritis, Rheumatoid; Female; Half-Life; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Pregnancy; Pregnancy Complications | 2001 |
Monitoring leflunomide (Arava) as a new potential teratogen.
Topics: Abnormalities, Drug-Induced; Arthritis, Rheumatoid; Female; Humans; Infant, Newborn; Isoxazoles; Leflunomide; Pregnancy; Teratogens | 2002 |
[An experimental study of carcinogenic activity of bucide and its effects on the reproductive function].
Topics: Abnormalities, Drug-Induced; Animals; Embryo, Mammalian; Female; Fungicides, Industrial; Gonads; Isoxazoles; Male; Neoplasms, Experimental; Pregnancy; Rats; Reproduction | 1991 |
[Reproductive and developmental toxicity study of mofezolac (N-22) (2)--Study by oral administration of N-22 during the period of fetal organogenesis in rats].
Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Coccyx; Embryonic and Fetal Development; Female; Gestational Age; Isoxazoles; Pregnancy; Rats; Rats, Inbred Strains; Reproduction; Sternum | 1990 |
[Reproductive and developmental toxicity study of mofezolac (N-22) (3)--Teratogenicity study in rabbits by oral administration].
Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Embryonic and Fetal Development; Female; Fetal Resorption; Gestational Age; Isoxazoles; Male; Pregnancy; Rabbits; Reproduction | 1990 |